Ventyx Biosciences (VTYX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VTYX Ventyx Biosciences

Watchlist

2.110
+0.030+1.44%

Close Oct 2 16:00 ET

2.153
+0.043+2.02%

Pre 08:38 ET

149.11MMarket Cap-758P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Maintains Target Price $10
Moomoo NewsSep 24 08:31 ET · Ratings
LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating
Moomoo NewsSep 23 22:31 ET · Ratings
LifeSci Capital Remains a Buy on Ventyx Biosciences (VTYX)
TipRanksSep 23 21:56 ET · Ratings
H.C. Wainwright Maintains Ventyx Biosciences(VTYX.US) With Hold Rating, Maintains Target Price $6
Moomoo NewsSep 23 12:32 ET · Ratings
Ventyx Biosciences: Cautious Optimism Amidst Sanofi's Strategic Investment and Upcoming Clinical Trials
TipRanksSep 23 12:15 ET
Market-Moving News for September 23rd
BenzingaSep 23 08:10 ET

Comments

Jaguar8

Sep 24 01:35

Ventyx Biosciences Price Target Maintained With a $6.00/Share by HC Wainwright & Co

$Ventyx Biosciences (VTYX.US)$

Stock_Drift

Sep 23 21:00

9/23/24 👀’s on_watchlist. 🚨🚨*not financial advice*

$Nuvve (NVVE.US)$ $Treasure Global (TGL.US)$ $Expion360 (XPON.US)$ $Black Diamond Therapeutics (BDTX.US)$ $Ventyx Biosciences (VTYX.US)$
📊⚡️📊

Jaguar8

Sep 23 20:26

“Sanofi has agreed to make a $27 million strategic investment in the Company at an as-converted price of $3.8243 per share of common stock”

$Ventyx Biosciences (VTYX.US)$

Jaguar8

Sep 23 20:03

NEWS

$Ventyx Biosciences (VTYX.US)$
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Sanofi has agreed to make a $27 million strategic investment in the Company at an as-converted price...